UNSPSC 51342102: Enviroxime

This classification denotes an antiviral agent with the molecular formula C17H18N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 133013L556, chemically known as 1h-benzimidazol-2-amine, 6-((hydroxyimino)phenylmethyl)-1-((1-methylethyl)sulfonyl)-, (e)- but generally known as enviroxime, which bears US NIH Compound Identifier 5748733. European Medicines Agency schedules Enviroxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06556MIG.

UNSPSC 51342102 Enviroxime is a Commodity code that captures state and local procurement of naloxone, drug deactivation systems, generic pharmaceuticals, and over-the-counter medical products for public health, emergency response, and healthcare delivery. The code spans community health initiatives, first-response programs, and pharmacy benefit programs operated by health departments, fire departments, and state human services agencies. Scope includes naloxone kits for overdose response, safe drug disposal and deactivation systems, medical and first aid consumables for emergency medical services, and manufacturer-direct pharmaceutical supply arrangements negotiated to improve cost efficiency and fulfillment velocity. Issuing bodies include county health departments, municipal fire departments, state health and human services commissions, and multi-state cooperative purchasing alliances. Work is typically solicited through competitive bidding (IFB), requests for proposals (RFP), and requests for information (RFI) mechanisms when market conditions or program design require vendor input before formal procurement.

Geographic activity spans Florida, Texas, Minnesota, and Oregon based on recent postings. Representative opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building; the City of Tampa Fire Department's IFB 26P00145 (posted March 25, 2026; due March 13, 2026) for 169 line items of medical and first aid supplies with an estimated contract value of $700,000 and SLBE set-aside protections; the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026; due April 3, 2026) seeking vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescription program; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson wholesalers with contract effectiveness July 1, 2026.